MedEdicus Podcasts
MedEdicus is an accredited, independent, leading developer of continuing medical education and disease awareness programs. We providee quality continuing education to health care providers and other members of the patient care team around the globe. Each of our learning opportunities offers a case-based approach to make the experience clinically relevant.MedEdicus is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians. We comply with all policies and guidelines of the US Food and Drug Administration, Office of Inspector General Guidance, and Pharmaceutical Research and Manufacturers of America Code.
(CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Cases in Clinical Practice - Part 1
Geographic atrophy is a growing healthcare concern for retina specialists caring for an aging population. In the first part of this podcast series titled, Improving Outcomes in Patients with Geographic Atrophy, our experts, Dr. Arshad Khanani and Dr. Lejla Vajzovic, will educate listeners on the disease epidemiology, pathophysiology, and relevant clinical features of GA on imaging. The discussion will include didactics presented by our experts and real-world case studies.
(CME Podcast) Improving Outcomes in Patients with Geographic Atrophy: Cases in Clinical Practice - Part 2
In part 2 of our podcast series on geographic atrophy, Dr. Lejla Vajzovic and Dr. Arshad Khanani will do a deep dive into current treatment options to optimize patient outcomes. Listeners will be enabled to develop treatment plans for patients with geographic atrophy through a review of clinical study data, case scenarios, and real-world cases. This comprehensive session will empower listeners to confidently assess and manage geographic atrophy in their practice.
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Diagnosis (CME/CE Podcast) - Part 1
This podcast, Part 1 of a 3-part series on thyroid eye disease (TED), explores the clinical features of both active and chronic disease, providing a foundation for understanding how to effectively diagnose and manage this condition. Through expert discussions, the faculty review key diagnostic tools and clinical signs, offering insights into the spectrum of TED activity and duration. Listeners will also gain guidance on selecting appropriate treatments tailored to varying stages of disease, preparing them to optimize care for patients with TED.
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Treatment (CE/CME Podcast) - Part 2
This podcast, Part 2 of a 3-part series on thyroid eye disease (TED), provides an in-depth discussion of treatment strategies, focusing on current medical and surgical options as well as emerging therapies. Faculty review clinical data on teprotumumab, the only FDA-approved agent for TED. Listeners will also be introduced to clinical data on treatments including glucocorticoids, orbital radiation, rituximab, and tocilizumab and learn how to select appropriate therapies across a spectrum of disease activity and duration.
Thyroid Eye Disease: Conversations on Comprehensive Comanagement: Monitoring (CE/CME Podcast) - Part 3
This podcast, Part 3 of a 3-part series on thyroid eye disease (TED), examines the multidisciplinary management of TED with a focus on teprotumumab-associated adverse effects. Through expert discussions and case-based examples, listeners will learn best practices for managing hyperglycemia, hearing changes, and other potential complications. The session outlines the essential role of primary eye care professionals in comanaging TED, from early recognition to educating patients and coordinating care with specialists. Clinicians will be equipped to apply collaborative strategies to optimize outcomes for TED patients.
Continuous Drug Delivery: Advancements in nAMD and DME (CME Podcast)
This program provides retina specialists and other ophthalmologists caring for patients with neovascular AMD and DME with a comprehensive overview of sustained-release therapies for retinal diseases. Participants will appraise the latest clinical data on the safety and efficacy of sustained delivery platforms, including the Port Delivery System (PDS) with ranibizumab, and emerging options like tyrosine kinase inhibitors and gene therapies. The program will detail the technical considerations for optimizing the safety and efficacy of sustained delivery, with a specific focus on the PDS surgical implantation and refill-exchange procedures. Through case-based discussions, learners will evaluate patient-specific characteristics...
(CE Podcast) Curbing Demodex Blepharitis: Meet the Mitey Challenge
Activity Description and Purpose
Demodex are ectoparasites that inhabit human hair follicles, including those on the face and eyelashes. Large infestations can cause Demodex blepharitis, a condition that has been associated with dry eye, meibomian gland dysfunction, and rosacea. Until recently, there were no US Food and Drug Administration–approved treatments for Demodex blepharitis, and off-label treatments were not reliably effective. This podcast covers the diagnosis and treatment of Demodex, including the recently approved treatment lotilaner, 0.25%.
Target Audience
This educational activity is intended for optometrists.
Learning Ob...
(CE/CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Epidemiology, Pathophysiology, and Imaging
Activity Description and Purpose
This educational activity delves into the latest clinical practices for managing geographic atrophy (GA), a severe form of dry age-related macular degeneration. Learners will gain an in-depth understanding of epidemiologic indicators, diagnostic imaging, and the pathophysiology of GA related to the complement cascade. Learners will also gain a deeper understanding of GA by reviewing a case study along with the expert presenters. Designed to enhance clinical knowledge and improve patient outcomes, this CME/CE activity offers a comprehensive approach to understanding and diagnosing GA in clinical practice. The...
(CE/CME Podcast) Improving Outcomes in Patients With Geographic Atrophy: Treatment and Referral
Activity Description and Purpose
This educational activity explores the advancements in geographic atrophy (GA) treatment options, focusing on clinical science data and real-world clinical presentations. Participants will gain insights into the latest US Food and Drug Administration–approved treatments, their mechanisms of action, clinical trial results, and patient safety considerations. Additionally, the educational activity emphasizes application in clinical practice via case examples, effective patient counseling techniques, and referral strategies to enhance patient outcomes and quality of life. This CME/CE activity is designed to enhance clinical competence and improve patient care in th...
Discussing Evaporative Dry Eye: Incorporating New Treatments Into Practice (CME/CE)
Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/discussing-evaporative-dry-eye-incorporating-new-treatments-practice-cmece-podcast
This podcast with Dr. Ken Beckman and Dr. Jaclyn Garlich delves into presentation and treatments of evaporative dry eye primarily caused by meibomian gland dysfunction (MGD). It explores the multifactorial nature of dry eye disease (DED), emphasizing the significance of MGD-driven DED, characterized by a deficient tear lipid layer. The discussion focuses on the latest treatment options, moving beyond traditional anti-inflammatory therapies to include newer topical solutions targeting evaporative loss. Real patient case studies contextualize these innovative approaches in the clinical...
Dry Eye Discussions: New Treatments for Meibomian Gland Dysfunction (CME/CE)
Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/discussing-evaporative-dry-eye-updates-diagnosis-and-new-treatments-cmece-podcast
Creating evidence-based treatment plans for those with DED requires a nuanced understanding of the role of tear film evaporation in eye health. This podcast features discussions between Leslie E. O’Dell, OD, FAAO and Lisa M. Nijm, MD, JD on evaporation in DED, gland expression, and new treatments. The activity also includes a visual component for learners. With a focus on practical applications and real-world examples, this podcast equips clinicians with the knowledge and strategies to manage evaporative DED effectively.
Rett Syndrome Update: Evolving Management Strategies (CME/CE)
Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/rtt-syndrome-update-evolving-management-strategies-cmece-podcastÂ
Dr Jeffrey Neul is an internationally recognized expert in Rett Syndrome and other genetic neurodevelopmental disorders. In this podcast, he talks to us about current guideline-directed management, clinical data for the first ever treatment for Rett syndrome, and another emerging disorder-specific therapy that is on the horizon. He also discusses the importance of multidisciplinary care in this disorder.Â
This educational activity is intended for pediatric neurologists, neurologists, nurse practitioners, physician assistants, and other clinicians who treat Rett syndrome.Â
Person-Centered Care Approaches to the Treatment of Patients With Neuropsychiatric Manifestations of Parkinson’s Disease - With Dr. Marc Agronin (CME/CE)
Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/person-centered-care-approaches-treatment-patients-neuropsychiatric-manifestations-0#group-tabs-node-course-default1
Dr. Agronin is a leading expert on psychiatric manifestations of Parkinson’s disease. In this podcast, he talks to us about diagnostic strategies, behavioral measures, and the pharmacologic treatment of Parkinson’s disease psychosis. Along the way, he shares insights from his decades in clinical practice and practical guidelines for the caregivers facing this challenging disease.
This educational activity is intended for psychiatric clinicians, including physicians, physician assistants, nurse practitioners, and nurses, caring for patients with Park...
